Abstract:One of the major disappointments in human autoimmunity has been the relative failure on genome-wide association studies to provide “smoking genetic guns” that would explain the critical role of genetic susceptibility to loss of tolerance. It is well known that autoimmunity refers to the abnormal state that the dysregulated immune system attacks the healthy cells and tissues due to the loss of immunological tolerance to self-antigens. Its clinical outcomes are generally characterized by the presence of autoreactive immune cells and (or) the development of autoantibodies, leading to various types of autoimmune disorders. The etiology and pathogenesis of autoimmune diseases are highly complex. Both genetic predisposition and environmental factors such as nutrition, infection, and chemicals are implicated in the pathogenic process of autoimmunity, however, how much and by what mechanisms each of these factors contribute to the development of autoimmunity remain unclear. Epigenetics, which refers to potentially heritable changes in gene expression and function that do not involve alterations of the DNA sequence, has provided us with a brand new key to answer these questions. In the recent decades, increasing evidence have demonstrated the roles of epigenetic dysregulation, including DNA methylation, histone modification, and noncoding RNA, in the pathogenesis of autoimmune diseases, especially systemic lupus erythematosus (SLE), which have shed light on a new era for autoimmunity research. Notably, DNA hypomethylation and reactivation of the inactive X chromosome are two epigenetic hallmarks of SLE. We will herein discuss briefly how genetic studies fail to completely elucidate the pathogenesis of autoimmune diseases and present a comprehensive review on landmark epigenetic findings in autoimmune diseases, taking SLE as an extensively studied example. The epigenetics of other autoimmune diseases such as rheumatic arthritis, systemic sclerosis and primary biliary cirrhosis will also be summarized. Importantly we emphasize that the stochastic processes that lead to DNA modification may be the lynch pins that drive the initial break in tolerance.

The Pathogenic Role of Dysregulated Epigenetic Modifications in Autoimmune Diseases.

Immunological pathogenesis and treatment of systemic lupus erythematosus

Epigenetics as biomarkers in autoimmune diseases.

The Critical Importance of Epigenetics in Autoimmunity

The critical role of epigenetics in systemic lupus erythematosus and autoimmunity

The Epigenetics of Lupus Erythematosus

Epigenetic Dynamics in Immunity and Autoimmunity

Epigenetic Perspectives in Systemic Lupus Erythematosus: Pathogenesis, Biomarkers, and Therapeutic Potentials.

The critical importance of epigenetics in autoimmune-related skin diseases

Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity

The emerging role of epigenetics in human autoimmune disorders

Insights into the Role of DNA Methylation in Immune Cell Development and Autoimmune Disease

Epigenetic Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus

Epigenetic Regulation of B Cells and Its Role in Autoimmune Pathogenesis

Dysregulated translational factors and epigenetic regulations orchestrate in B cells contributing to autoimmune diseases

Translating epigenetics into clinic: focus on lupus

Epigenetics and Psoriasis.

Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders

Epigenetic Dysregulation in Autoimmune and Inflammatory Skin Diseases

Epigenetics of Autoimmune Liver Diseases: Current Progress and Future Directions

DNA methylation perspectives in the pathogenesis of autoimmune diseases.